Bariatric procedures are considered to be the most effective treatment options for obesity. One of them is laparoscopic sleeve gastrectomy (LSG), which is nowadays very popular and widely used. LSG leads to weight loss and metabolic improvement and also changes adipokine levels, although it is just a restrictive operation. We describe changes in pro-inflammatory (leptin, resistin, visfatin and chemerin) and anti-inflammatory adipokines (adiponectin, omentin), with adiponectin and leptin being most studied. Their levels are markedly changed after LSG and this may partially explain the weight loss seen after LSG. Adipokines are closely connected to insulin resistance and chronic inflammation both being positively influenced after LSG. Leptin regulates amount of body fat, appetite, thermogenesis and metabolic rate and its levels are positively correlated with both weight and BMI changes after operation. Resistin influences insulin sensitivity, modulates body cholesterol trafficking and its changes after operation correlate with BMI, waist circumference, fat mass, LDL cholesterol and C-reactive protein. Chemerin, an important component of immune system, decreases after bariatric surgery and its levels correlate with BMI, triglyceride levels, and blood glucose. On the other hand, pro-inflammatory adipokine adiponectin, which influences fatty acid oxidation, browning of fat tissue and energy metabolism, is declining after LSG. This decline explains improvement of glucose status after bariatric surgery in patients with diabetes and is correlated with BMI loss, waist circumference and LDL cholesterol level. Effect of LSG goes beyond calory restriction and the changes of adipokines have a great impact on health status of the bariatric patients.

Department of Internal Medicine 3 Nephrology Rheumatology and Endocrinology Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic

Zobrazit více v PubMed

Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288–298. doi: 10.1038/s41574-019-0176-8. PubMed DOI

Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10. doi: 10.1016/j.metabol.2018.09.005. PubMed DOI

Bray GA, Ryan DH. Evidence-based weight loss interventions: Individualized treatment options to maximize patient outcomes. Diabetes Obes Metab. 2021;23(Suppl 1):50–62. doi: 10.1111/dom.14200. PubMed DOI

Salman MA, El-Ghobary M, Soliman A, El Sherbiny M, Abouelregal TE, Albitar A, Abdallah A, Mikhail HMS, Nafea MA, Sultan AAEA, Elshafey HE, Shaaban HE, Azzam A, GabAllah GMK, Salman AA. Long-term changes in Leptin, Chemerin, and Ghrelin levels following Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Obes Surg. 2020;30:1052–1060. doi: 10.1007/s11695-019-04254-z. PubMed DOI

Brethauer SA. Sleeve gastrectomy. Surg Clin N Am. 2011;91:1265–1279. doi: 10.1016/j.suc.2011.08.012. PubMed DOI

Benaiges D, Más-Lorenzo A, Goday A, Ramon JM, Chillarón JJ, Pedro-Botet J, Flores-Le Roux JA. Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure? World J Gastroenterol. 2015;21:11804–11814. doi: 10.3748/wjg.v21.i41.11804. PubMed DOI PMC

Huang R, Ding X, Fu H, Cai Q. Potential mechanisms of sleeve gastrectomy for reducing weight and improving metabolism in patients with obesity. Surg Obes Relat Dis. 2019;15:1861–1871. doi: 10.1016/j.soard.2019.06.022. PubMed DOI

Moncada R, Becerril S, Rodríguez A, Méndez-Giménez L, Ramírez B, Catalán V, Gómez-Ambrosi J, Gil MJ, Fernández S, Cienfuegos JA, Valentí V, Frühbeck G. Sleeve gastrectomy reduces body weight and improves metabolic profile also in obesity-prone rats. Obes Surg. 2016;26:1537–1548. doi: 10.1007/s11695-015-1915-. PubMed DOI

Lopez-Nava G, Negi A, Bautista-Castaño I, Rubio MA, Asokkumar R. Gut and metabolic hormones changes after endoscopic sleeve gastroplasty (ESG) vs. Laparoscopic sleeve gastrectomy (LSG) Obes Surg. 2020;30:2642–2651. doi: 10.1007/s11695-020-04541-0. PubMed DOI

de Luis DA, Sagrado MG, Conde R, Aller R, Izaola O, de la Fuente B, Castrillón JL, Romero E. Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in naïve diabetes obese patients. Diabetes Res Clin Pract. 2010;89:110–114. doi: 10.1016/j.diabres.2010.03.031. PubMed DOI

Šebunova N, Štšepetova J, Kullisaar T, Suija K, Rätsep A, Junkin I, Soeorg H, Lember M, Sillakivi T, Mändar R. Changes in adipokine levels and metabolic profiles following bariatric surgery. BMC Endocr Disord. 2022;22:33. doi: 10.1186/s12902-022-00942-7. PubMed DOI PMC

Huang J, Chen Y, Wang X, Wang C, Yang J, Guan B. Change in adipokines and gastrointestinal hormones after bariatric surgery: a meta-analysis. Obes Surg. 2023 Jan 6; doi: 10.1007/s11695-022-06444-8. Epub ahead of print. PubMed DOI

Osorio-Conles O, Vida J, Hollanda A. Impact of bariatric surgery on adipose tissue biology. J Clin Med. 2021;10:5516. doi: 10.3390/jcm10235516. PubMed DOI PMC

Marantos G, Deskalakis M, Karkavitsas N, Matalliotakis I, Papadakis JA, Melissas J. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery. World J Surg. 2011;35:2022–2030. doi: 10.1007/s00268-011-1165-9. PubMed DOI

Mazahreh TS, Alfaqih M, Saadeh R, Al-Zoubi NA, Hatamleh M, Alqudah A, Aleshawi AJ, Alzoubi A. The effects of laparoscopic sleeve gastrectomy on the parameters of leptin resistance in obesity. Biomolecules. 2019;9:533. doi: 10.3390/biom9100533. PubMed DOI PMC

Park HK, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism. 2015;64:24–34. doi: 10.1016/j.metabol.2014.08.004. PubMed DOI PMC

Stefater MA, Perez-Tilve D, Chambers AP, Wilson-Perez HE, Sandoval DA, Berger J, Toure M, Tschop M, Woods SC, Seeley RJ. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology. 2010;138:2426–236. doi: 10.1053/j.gastro.2010.02.059. PubMed DOI PMC

Rafey MF, Fang CEH, Ioana I, Griffin H, Hynes M, O’Brien T, McAnena O, O’Shea P, Collins C, Davenport C, Finucane FM. The leptin to adiponectin ratio (LAR) is reduced by sleeve gastrectomy in adults with severe obesity: a prospective cohort study. Sci Rep. 2020 Oct 1;10(1):16270. doi: 10.1038/s41598-020-73520-3. PubMed DOI PMC

Salman MA, Salman AA, Nafea MA, Sultan AAEA, Anwar HW, Ibrahim AH, Awad A, Ahmed RA, Seif El Nasr SM, Abouelregal TE, Shaaban HE, Mohamed FAH. Study of changes of obesity-related inflammatory cytokines after laparoscopic sleeve gastrectomy. ANZ J Surg. 2019 Oct;89(10):1265–1269. doi: 10.1111/ans.15427. PubMed DOI

Salman AA, Sultan AAEA, Abdallah A, Abdelsalam A, Mikhail HMS, Tourky M, Omar MG, Youssef A, Ahmed RA, Elkassar H, Seif El Nasr SM, Shaaban HE, Atallah M, GabAllah GMK, Salman MA. Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels. J Gastroenterol Hepatol. 2020 Oct;35(10):1769–1773. doi: 10.1111/jgh.15029. PubMed DOI

Min T, Prior SL, Dunseath G, Churm R, Barry JD, Stephens JW. Temporal effects of bariatric surgery on adipokines, inflammation and oxidative stress in subjects with impaired glucose homeostasis at 4 years follow-up. Obesity surgery. 2020;30:1712–1718. doi: 10.1007/s11695-019-04377-3. PubMed DOI PMC

Shuldiner AR, Yang R, Gong DW. Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ. N Engl J Med. 2001 Nov 1;345(18):1345–6. doi: 10.1056/NEJM200111013451814. PubMed DOI

Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature. 2001 Jan 18;409(6818):307–12. doi: 10.1038/35053000. PubMed DOI

Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler J, Richart C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004 Jun;12(6):962–71. doi: 10.1038/oby.2004.118. PubMed DOI

de Luis DA, Sagrado MG, Aller R, Conde R, Izaola O. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle. Nutrition. 2010 Nov–Dec;26(11–12):1130–3. doi: 10.1016/j.nut.2008.11.019. PubMed DOI

Rourke JL, Dranse HJ, Sinal CJ. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obes Rev. 2013 Mar;14(3):245–62. doi: 10.1111/obr.12009. PubMed DOI

Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, Konstantopoulos N, Morrison S, Carless M, Dyer TD, Cole SA, Goring HH, Moses EK, Walder K, Cawthorne MA, Blangero J, Jowett JB. Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab. 2010;95:2476–2485. doi: 10.1210/jc.2010-0042. PubMed DOI PMC

Terra X, Auguet T, Guiu-Jurado E, Berlanga A, Orellana-Gavaldà JM, Hernández M, Sabench F, Porras JA, Llutart J, Martinez S, Aguilar C, Del Castillo D, Richart C. Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2013;23:1790–1798. doi: 10.1007/s11695-013-1033-9. PubMed DOI

Liu L, Zhang T, Hu J, Ma R, He B, Wang M, Wang Y. Adiponectin/SIRT1 axis induces white adipose browning after vertical sleeve gastrectomy of obese rats with type 2 diabetes. Obes Surg. 2020;30:1392–1403. doi: 10.1007/s11695-019-04295-4. PubMed DOI

Lapointe M, Poirier P, Martin J, Bastien M, Auclair A, Cianflone K. Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease. Cardiovasc Diabetol. 2014;13:124. doi: 10.1186/s12933-014-0124-9. PubMed DOI PMC

Farey JE, Preda TC, Fisher OM, Levert-Mignon AJ, Stewart RL, Karsten E, Herbert BR, Swarbrick MM, Lord RV. Effect of laparoscopic sleeve gastrectomy on fasting gastrointestinal, pancreatic, and adipose-derived hormones and on non-esterified fatty acids. Obes Surg. 2017;27:399–407. doi: 10.1007/s11695-016-2302-1. PubMed DOI PMC

Parreño Caparrós E, Illán Gómez F, Gonzálvez Ortega M, Orea Soler I, Pérez Paredes M, Lozano Almela ML, Arjonilla Sampedro E, Alcaráz Tafalla M. Resistin in morbidly obese patients before and after gastric bypass surgery. Nutr Hosp. 2017;34:1333–1337. doi: 10.20960/nh.1028. PubMed DOI

Al-Harithy RN, Al-Ghamdi S. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus. Ann Saudi Med. 2005;25:283–7. doi: 10.5144/0256-4947.2005.283. PubMed DOI PMC

Adipokine Levels of RBP4, Resistin and Nesfatin-1 in Women Diagnosed With Gestational Diabetes